Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TN › Bolivar › NPI 1518957950
Hospital

Bolivar General Hospital, INC.

Bolivar General Hospital, INC. was paid $2.36M by Medicaid between Jan 2018 and Dec 2024, across 43 billing codes. Its largest line is 99283, emergency room visit (moderate) — 44% of everything it billed.

33Billing provider infoBOLIVAR GENERAL HOSPITAL, INC.
BOLIVAR, TN 38008
33aNPI1518957950assigned 10/26/2005
28Total paid$2.36M
24GClaims63,428
24DCodes billed43
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Medicare Defined Swing Bed Hospital Unit providers in Tennessee

Rank by total paid#2 of 5
Median peer was paid$1.63M
This provider vs. median1.4×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official PRESCOTT, TINA controls 17+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$20K$40K$60K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201814,696$499K
201912,340$430K
20207,067$274K
20217,132$285K
20229,275$368K
20238,403$303K
2024incomplete4,515$199K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 44% 10,476 9,172 $1.03M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 36% 5,188 4,438 $858K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 7.0% 1,116 913 $165K
99282 Emergency department visit for the evaluation and management, low to moderate severity 3.7% 1,210 1,107 $87K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 1.7% 1,695 1,606 $40K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.6% 9,381 7,734 $37K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 3,915 3,160 $22K
80053 Comprehensive metabolic panel <1% 6,042 4,992 $18K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 2,460 2,208 $16K
36415 Collection of venous blood by venipuncture <1% 9,232 7,507 $12K
G0378 Hospital observation service, per hour <1% 90 60 $12K
84484 <1% 1,333 1,057 $12K
31 more codes
71045 Radiologic examination, chest; single view <1% 1,978 $5K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 141 $5K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 1,443 $5K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 537 $4K
87430 <1% 1,067 $4K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 166 $3K
80048 Basic metabolic panel (calcium, ionized) <1% 877 $3K
70450 Computed tomography, head or brain; without contrast material <1% 120 $2K
81001 <1% 2,896 $2K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 144 $2K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 205 $2K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 32 $2K
83605 <1% 170 $1K
83690 <1% 240 $812.39
83880 <1% 152 $747.00
96375 Therapeutic injection; each additional sequential IV push <1% 131 $672.84
81025 <1% 205 $593.38
71046 Radiologic examination, chest; 2 views <1% 137 $562.75
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 16 $546.56
87081 <1% 149 $445.98
87807 <1% 70 $272.14
83735 <1% 50 $159.12
80305 <1% 56 $139.24
80076 <1% 31 $93.54
80061 Lipid panel <1% 48 $79.77
82150 <1% 18 $68.72
84100 <1% 34 $58.56
84550 <1% 20 $3.82
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 0% 15 $0.00
A9270 Non-covered item or service 0% 126 $0.00
84443 Thyroid stimulating hormone (TSH) 0% 16 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialPRESCOTT, TINA (PRESIDENT AND CEO)
Same official

Other billing entities under PRESCOTT, TINA

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.